BCAB - Company ID 0001826892
BioAtla, Inc. trades as BCAB. This page tracks BioAtla, Inc. through 486 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
With latest filings
Next research step
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| Quarterly report | 10-Q | 2026-05-15 |
| Annual report (amended) | 10-K/A | 2026-04-29 |
| Major company event | 8-K | 2026-04-02 |
| Major company event | 8-K | 2026-03-31 |
| Annual report | 10-K | 2026-03-31 |
| Employee stock plan | S-8 | 2026-03-31 |
| Major company event | 8-K | 2026-03-23 |
| Prospectus supplement | 424B2 | 2026-03-20 |
The largest companies sharing BioAtla, Inc.'s SEC industry classification (biological products, (no diagnostic substances)).
In its latest fiscal year BioAtla, Inc. reported a net loss of $59.61M.